Acrivon Therapeutics, Inc. (ACRV): S-8 filed Aug 12, 2026

Form type

S-8

Filing date

Aug 12, 2026

Accession number

0001193125-26-347003

Filer

Acrivon Therapeutics, Inc. (CIK 1781174)